Amjid Iqbal, a distinguished researcher and visionary leader, is the Director of ThinkbioTech, where he combines his extensive research expertise and academic accomplishments to drive scientific innovation and promote open access to knowledge. With a Doctorate degree from the prestigious University of Cambridge, Amjid Iqbal’s educational foundation exemplifies excellence in the field of science and research.

Amjid Iqbal’s journey in academia has led him to specialize in several prominent areas, including Chemical Biology, Medicinal Chemistry, Organic Chemistry, Imine chemistry, Enzymology, and Heterocyclic Chemistry. His doctoral research at the University of Cambridge was a testament to his dedication and passion for delving into the intricacies of these disciplines, making invaluable contributions to scientific understanding.

In the realm of Chemical Biology, Amjid Iqbal has explored the fascinating interplay between chemical compounds and biological systems, elucidating the underlying mechanisms governing vital life processes. His expertise in Medicinal Chemistry has been instrumental in designing and synthesizing novel pharmaceutical compounds, with the potential to revolutionize drug development and improve healthcare outcomes.

Amjid Iqbal’s work in Organic Chemistry has yielded significant advancements in the synthesis and design of various organic molecules, opening up new avenues for applications in diverse scientific domains. His research on Schiff Bases has underscored the versatility of these organic compounds, showcasing their potential in coordination chemistry, catalysis, and medicinal chemistry.

As an expert in Enzymology, Amjid Iqbal’s profound understanding of enzymatic functions and mechanisms has contributed to unraveling the complexity of biological processes, presenting opportunities for therapeutic interventions and furthering our understanding of cellular activities. Additionally, his explorations in Hydrogen Bonding have provided essential insights into this fundamental phenomenon, influencing molecular structure and reactivity in remarkable ways.

Amjid Iqbal’s expertise extends to Heterocyclic Chemistry, where he has undertaken pioneering research on the synthesis and applications of novel heterocyclic compounds, contributing to advancements across multiple scientific disciplines.

In addition to his remarkable research accomplishments, Amjid Iqbal’s leadership at ThinkbioTech is marked by his experience in running multiple specialized journals. Under his guidance, ThinkbioTech oversees and manages an array of prestigious journals, each dedicated to fostering collaboration and knowledge exchange among researchers and professionals worldwide. These journals include the Journal Of Natural Science, Biology & Medicine, Journal of Commercial Biotechnology, FishTaxa – Journal of Fish Taxonomy, Jornal Brasileiro de Patologia e Medicina Laboratorial, Vascular and Endovascular Review (VER), The Review of Diabetic Studies, Revista Internacional De Medicina Y Ciencias De La Actividad Física Y Del Deporte, and Journal of Carcinogenesis. Under his direction, these journals have become prominent platforms for disseminating cutting-edge research and facilitating multidisciplinary collaboration.

Amjid Iqbal’s background in leading-edge research and his profound impact in various scientific fields have earned him the utmost respect and admiration among his peers and the global scientific community. With his doctoral training from the University of Cambridge and his continued dedication to education and mentorship, he remains committed to nurturing the next generation of researchers and driving scientific progress for the betterment of society.

As the Director of ThinkbioTech, Amjid Iqbal continues to be a driving force in shaping the future of biological sciences and related disciplines, leveraging his exceptional knowledge, leadership skills, and unwavering commitment to advancing science. His contributions to academia and his ongoing dedication to the pursuit of knowledge have solidified his place as a transformative figure in the scientific landscape.